BackLyra Therapeutics Overview

Lyra Therapeutics Other Assets

Latest other assets for LYRA: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

Lyra Therapeutics Other Assets History

Loading

Lyra Therapeutics vs. peers: Other Assets Comparison

Loading

Lyra Therapeutics Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lyra Therapeutics (LYRA) FAQ

Lyra Therapeutics (LYRA) currently reports a other assets of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Lyra Therapeutics's other assets history and peer comparisons.

Lyra Therapeutics's other assets changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lyra Therapeutics reported $0 in other assets as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lyra Therapeutics, and consider following LYRA for alerts when major investors trade the stock.

Lyra Therapeutics is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LYRA with unrelated industries.